Dileep KV, Ihara K, Mishima-Tsumagari C, Kukimoto-Niino M, Yonemochi M, Hanada K, Shirouzu M, Zhang KYJ (2022) <br />Crystal structure of human acetylcholinesterase in complex with tacrine: Implications for drug discovery<br /><i>Int J Biol Macromol</i> <b>210</b>: 172<br /><br />Alhomida AS, Al-Rajhi AA, Kamal MA, Al-Jafari AA (2000) <br />Kinetic analysis of the toxicological effect of tacrine (Cognex) on human retinal acetylcholinesterase activity<br /><i>Toxicology</i> <b>147</b>: 33<br /><br />Camps P, Cusack B, Mallender WD, Achab RE, Morral J, Munoz-Torrero D, Rosenberry TL (2000) <br />Huprine X is a Novel High-Affinity Inhibitor of Acetylcholinesterase That Is of Interest for Treatment of Alzheimer's Disease<br /><i>Molecular Pharmacology</i> <b>57</b>: 409<br /><br />Heuser G (2000) <br />Mass psychogenic illness attributed to toxic exposure at a high school<br /><i>N Engl J Med</i> <b>342</b>: 1674; author reply 1675<br /><br />Callahan MJ (1999) <br />Combining tacrine with milameline reverses a scopolamine-induced impairment of continuous performance in rhesus monkeys<br /><i>Psychopharmacology (Berl)</i> <b>144</b>: 234<br /><br />Traykov L, Tavitian B, Jobert A, Boller F, Forette F, Crouzel C, Di Giamberardino L, Pappata S (1999) <br />In vivo PET study of cerebral [11C] methyl- tetrahydroaminoacridine distribution and kinetics in healthy human subjects<br /><i>Eur Journal of Neurology</i> <b>6</b>: 273<br /><br />Zhao S, Totleben MJ, Freeman JP, Bacon CL, Fox GB, O'Driscoll E, Foley AG, Kelly J, Farrell U, Regan C, Mizsak SA, Szmuszkovicz J (1999) <br />Syntheses of benzoquinolizidine and benzoindolizidine derivatives as anti-amnesic agents<br /><i>Bioorganic & Medicinal Chemistry</i> <b>7</b>: 1637<br /><br />Allal C, Lazartigues E, Tran MA, Brefel-Courbon C, Gharib C, Montastruc JL, Rascol O (1998) <br />Central cardiovascular effects of tacrine in the conscious dog: a role for catecholamines and vasopressin release<br /><i>European Journal of Pharmacology</i> <b>348</b>: 191<br /><br />Badia A, Banos JE, Camps P, Contreras J, Gorbig DM, Munoz-Torrero D, Simon M, Vivas NM (1998) <br />Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease<br /><i>Bioorganic & Medicinal Chemistry</i> <b>6</b>: 427<br /><br />Cheng DH, Tang XC (1998) <br />Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities<br /><i>Pharmacol Biochem Behav</i> <b>60</b>: 377<br /><br />Costagli C, Galli A (1998) <br />Inhibition of cholinesterase-associated aryl acylamidase activity by anticholinesterase agents: focus on drugs potentially effective in Alzheimer's disease<br /><i>Biochemical Pharmacology</i> <b>55</b>: 1733<br /><br />De Ferrari GV, Von Bernhardi R, Calderon FH, Luza SC, Inestrosa NC (1998) <br />Responses induced by tacrine in neuronal and non-neuronal cell lines<br /><i>Journal of Neuroscience Research</i> <b>52</b>: 435<br /><br />Giacobini E (1998) <br />Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications<br /><i>Neurochem Int</i> <b>32</b>: 413<br /><br />Giovannini MG, Scali C, Bartolini L, Schmidt B, Pepeu G (1998) <br />Effect of subchronic treatment with metrifonate and tacrine on brain cholinergic function in aged F344 rats<br /><i>European Journal of Pharmacology</i> <b>354</b>: 17<br /><br />Gracon SI, Knapp MJ, Berghoff WG, Pierce M, DeJong R, Lobbestael SJ, Symons J, Dombey SL, Luscombe FA, Kraemer D (1998) <br />Safety of tacrine: clinical trials, treatment IND, and postmarketing experience<br /><i>Alzheimer Disease & Associated Disorders</i> <b>12</b>: 93<br /><br />Grothe DR, Piscitelli SC, Dukoff R, Fullerton T, Sunderland T, Molchan SE (1998) <br />Penetration of tacrine into cerebrospinal fluid in patients with Alzheimer's disease<br /><i>J Clin Psychopharmacol</i> <b>18</b>: 78<br /><br />Meyer EM, King MA, Meyers C (1998) <br />Neuroprotective effects of 2,4-dimethoxybenzylidene anabaseine (DMXB) and tetrahydroaminoacridine (THA) in neocortices of nucleus basalis lesioned rats<br /><i>Brain Research</i> <b>786</b>: 252<br /><br />Monteith DK, Theiss JC, Haskins JR, de la Iglesia FA (1998) <br />Functional and subcellular organelle changes in isolated rat and human hepatocytes induced by tetrahydroaminoacridine<br /><i>Archives of Toxicology</i> <b>72</b>: 147<br /><br />O'Neill J, Fitten LJ, Siembieda D, Halgren E, Kim E, Fisher A, Perryman K (1998) <br />Effects of AF102B and tacrine on delayed match-to-sample in monkeys<br /><i>Prog Neuropsychopharmacol Biological Psychiatry</i> <b>22</b>: 665<br /><br />Pavone F, Capone F, Battaglia M, Sansone M (1998) <br />Shuttle-box avoidance learning in mice: improvement by combined glucose and tacrine<br /><i>Neurobiol Learn Mem</i> <b>69</b>: 204<br /><br />Riekkinen M, Soininen H, Riekkinen P, Sr., Kuikka J, Laakso M, Helkala EL, Partanen J, Riekkinen P, Jr. (1998) <br />Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease<br /><i>Neuroscience</i> <b>83</b>: 471<br /><br />Riekkinen P, Jr., Ikonen S, Riekkinen M (1998) <br />Tetrahydroaminoacridine, a cholinesterase inhibitor, and D-cycloserine, a partial NMDA receptor-associated glycine site agonist, enhances acquisition of spatial navigation<br /><i>Neuroreport</i> <b>9</b>: 1633<br /><br />Svensson AL, Nordberg A (1998) <br />Tacrine and donepezil attenuate the neurotoxic effect of A beta(25-35) in rat PC12 cells<br /><i>Neuroreport</i> <b>9</b>: 1519<br /><br />Vargas MG, Havel J, Patocka J (1998) <br />Capillary zone electrophoretic determination of some drugs against Alzheimer's disease<br /><i>Journal of Chromatography A</i> <b>802</b>: 121<br /><br />Wang T, Tang XC (1998) <br />Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine<br /><i>European Journal of Pharmacology</i> <b>349</b>: 137<br /><br />Al-Jafari AA, Kamal MA, Alhomida AS (1998) <br />Sensitivity of bovine retinal acetylcholinesterase (E.C. 3.1.1.7) toward tacrine: kinetic characterization<br /><i>J Biochem Mol Toxicol</i> <b>12</b>: 245<br /><br />Bonan CD, Battastini AM, Schetinger MR, Moreira CM, Frassetto SS, Dias RD, Sarkis JJ (1997) <br />Effects of 9-amino-1,2,3,4-tetrahydroacridine (THA) on ATP diphosphohydrolase (EC 3.6.1.5) and 5'-nucleotidase (EC 3.1.3.5) from rat brain synaptosomes<br /><i>General Pharmacology</i> <b>28</b>: 761<br /><br />Carriero DL, Outslay G, Mayorga AJ, Aberman J, Gianutsos G, Salamone JD (1997) <br />Motor dysfunction produced by tacrine administration in rats<br /><i>Pharmacol Biochem Behav</i> <b>58</b>: 851<br /><br />Cousins MS, Carriero DL, Salamone JD (1997) <br />Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs<br /><i>European Journal of Pharmacology</i> <b>322</b>: 137<br /><br />Gracon S, Smith F, Shokry A (1997) <br />[Advantages in long-term treatment with Cognex in Alzheimer disease]<br /><i>Schweiz Rundsch Med Prax</i> <b>86</b>: 1350<br /><br />Harder JA, Kelly ME (1997) <br />The effect of several putative cognition enhancers on a water maze acquisition deficit produced by pCPA + scopolamine combination treatment<br /><i>Pharmacol Biochem Behav</i> <b>56</b>: 657<br /><br />Ibebunjo C, Donati F, Fox GS, Eshelby D, Tchervenkov JI (1997) <br />The effects of chronic tacrine therapy on d-tubocurarine blockade in the soleus and tibialis muscles of the rat<br /><i>Anesthesia & Analgesia</i> <b>85</b>: 431<br /><br />Jakala P, Riekkinen P, Jr. (1997) <br />Combined cholinergic and 5-HT2 receptor activation suppresses thalamocortical oscillations in aged rats<br /><i>Pharmacol Biochem Behav</i> <b>56</b>: 713<br /><br />Kojima J, Nakajima K, Ochiai M, Nakayama K (1997) <br />Effects of NIK-247 on cholinesterase and scopolamine-induced amnesia [published erratum appears in Methods Find Exp Clin Pharmacol 1997 Jun;19(5):364]<br /><i>Methods Find Exp Clin Pharmacol</i> <b>19</b>: 245<br /><br />Lahiri DK, Farlow MR, Nurnberger JI, Jr., Greig NH (1997) <br />Effects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell cultures<br /><i>Annals of the New York Academy of Sciences</i> <b>826</b>: 416<br /><br />McGuffey EC (1997) <br />Alzheimer's disease: an overview for the pharmacist<br /><i>J Am Pharm Assoc</i> <b>3</b>: 347<br /><br />Pavone F, Battaglia M, Sansone M (1997) <br />Prevention of amitriptyline-induced avoidance impairment by tacrine in mice<br /><i>Behavioural Brain Research</i> <b>89</b>: 229<br /><br />Pike BR, Hamm RJ, Temple MD, Buck DL, Lyeth BG (1997) <br />Effect of tetrahydroaminoacridine, a cholinesterase inhibitor, on cognitive performance following experimental brain injury<br /><i>Journal of Neurotrauma</i> <b>14</b>: 897<br /><br />Pomponi M, Marta M, Colella A, Sacchi S, Patamia M, Gatta F, Capone F, Oliverio A, Pavone F (1997) <br />Studies on a new series of THA analogues: effects of the aromatic residues that line the gorge of AChE<br /><i>FEBS Letters</i> <b>409</b>: 155<br /><br />Pool WF, Reily MD, Bjorge SM, Woolf TF (1997) <br />Metabolic disposition of the cognition activator tacrine in rats, dogs, and humans. Species comparisons<br /><i>Drug Metabolism & Disposition: The Biological Fate of Chemicals</i> <b>25</b>: 590<br /><br />Riekkinen P, Jr., Riekkinen M, Soininen H, Kuikka J, Laakso M, Riekkinen P, Sr. (1997) <br />Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease<br /><i>Neuroreport</i> <b>8</b>: 1845<br /><br />Rupniak NM, Tye SJ, Field MJ (1997) <br />Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys<br /><i>Psychopharmacology</i> <b>131</b>: 406<br /><br />Sharma A, Parikh V, Singh M (1997) <br />Pharmacological basis of drug therapy of Alzheimer's disease<br /><i>Indian J Exp Biol</i> <b>35</b>: 1146<br /><br />Tsukada H, Kakiuchi T, Ando I, Ouchi Y (1997) <br />Functional activation of cerebral blood flow abolished by scopolamine is reversed by cognitive enhancers associated with cholinesterase inhibition: a positron emission tomography study in unanesthetized monkeys<br /><i>Journal of Pharmacology & Experimental Therapeutics</i> <b>281</b>: 1408<br /><br />Bezek S, Kukan M, Pool WF, Woolf TF (1996) <br />The effect of cytochromes P4501A induction and inhibition on the disposition of the cognition activator tacrine in rat hepatic preparations<br /><i>Xenobiotica</i> <b>26</b>: 935<br /><br />Cheng DH, Ren H, Tang XC (1996) <br />Huperzine A, a novel promising acetylcholinesterase inhibitor<br /><i>Neuroreport</i> <b>8</b>: 97<br /><br />Forgue ST, Reece PA, Sedman AJ, deVries TM (1996) <br />Inhibition of tacrine oral clearance by cimetidine<br /><i>Clinical Pharmacology & Therapeutics</i> <b>59</b>: 444<br /><br />Foster NL, Petersen RC, Gracon SI, Lewis K (1996) <br />An enriched-population, double-blind, placebo-controlled, crossover study of tacrine and lecithin in Alzheimer's disease. The Tacrine 970-6 Study Group<br /><i>Dementia</i> <b>7</b>: 260<br /><br />Gnagey AL, Ellis J (1996) <br />Allosteric regulation of the binding of [3H]acetylcholine to m2 muscarinic receptors<br /><i>Biochemical Pharmacology</i> <b>52</b>: 1767<br /><br />Jackson JJ, Soliman MR (1996) <br />Effects of tacrine (THA) on spatial reference memory and cholinergic enzymes in specific rat brain regions<br /><i>Life Sciences</i> <b>58</b>: 47<br /><br />Loewenstein-Lichtenstein Y, Glick D, Gluzman N, Sternfeld M, Zakut H, Soreq H (1996) <br />Overlapping drug interaction sites of human butyrylcholinesterase dissected by site-directed mutagenesis<br /><i>Molecular Pharmacology</i> <b>50</b>: 1423<br /><br />Scheen AJ (1996) <br />[Pharma-clinics. Drug of the month. Tacrine (Cognex)]<br /><i>Rev Med Liege</i> <b>51</b>: 379<br /><br />Shafazand M (1996) <br />[Alzheimer disease cannot be treated with Cognex]<br /><i>Lakartidningen</i> <b>93</b>: 1406<br /><br />Pacheco G, Palacios-Esquivel R, Moss DE (1995) <br />Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase<br /><i>Journal of Pharmacology & Experimental Therapeutics</i> <b>274</b>: 767<br /><br />Pirrung MC, Chau JH, Chen J (1995) <br />Discovery of a novel tetrahydroacridine acetylcholinesterase inhibitor through an indexed combinatorial library<br /><i>Chemistry & Biology</i> <b>2</b>: 621<br /><br />Rouhart F (1995) <br />[New therapeutic prospects in Alzheimer disease]<br /><i>Rev Med Interne</i> <b>16</b>: 860<br /><br />Murai S, Saito H, Abe E, Masuda Y, Odashima J, Itoh T (1994) <br />MKC-231, a choline uptake enhancer, ameliorates working memory deficits and decreased hippocampal acetylcholine induced by ethylcholine aziridinium ion in mice<br /><i>Journal of Neural Transmission General Section</i> <b>98</b>: 1<br /><br />Adem A (1993) <br />The next generation of cholinesterase inhibitors<br /><i>Acta Neurologica Scandinavica Supplementum</i> <b>149</b>: 10<br /><br />Bajgar J, Skopec F (1993) <br />Changes of rat blood and tissue cholinesterases following administration of tacrine derivatives in vivo<br /><i>Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity</i> <b>36</b>: 73<br /><br />Messamore E, Warpman U, Ogane N, Giacobini E (1993) <br />Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex<br /><i>Neuropharmacology</i> <b>32</b>: 745<br /><br />Radic Z, Pickering NA, Vellom DC, Camp S, Taylor P (1993) <br />Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors<br /><i>Biochemistry</i> <b>32</b>: 12074<br /><br />Galli A, Mori F, Gori I, Lucherini M (1992) <br />In vitro protection of acetylcholinesterase and butyrylcholinesterase by tetrahydroaminoacridine. Comparison with physostigmine<br /><i>Biochemical Pharmacology</i> <b>43</b>: 2427<br /><br />Ogane N, Giacobini E, Messamore E (1992) <br />Preferential inhibition of acetylcholinesterase molecular forms in rat brain<br /><i>Neurochemical Research</i> <b>17</b>: 489<br /><br />Braga MF, Harvey AL, Rowan EG (1991) <br />Effects of tacrine, velnacrine (HP029), suronacrine (HP128), and 3,4-diaminopyridine on skeletal neuromuscular transmission in vitro<br /><i>British Journal of Pharmacology</i> <b>102</b>: 909<br /><br />Dawson RM (1990) <br />Reversibility of the inhibition of acetylcholinesterase by tacrine<br /><i>Neuroscience Letters</i> <b>118</b>: 85<br /><br />Hunter AJ, Murray TK, Jones JA, Cross AJ, Green AR (1989) <br />The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro<br /><i>British Journal of Pharmacology</i> <b>98</b>: 79<br /><br />Robinson TN, De Souza RJ, Cross AJ, Green AR (1989) <br />The mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prisms<br /><i>British Journal of Pharmacology</i> <b>98</b>: 1127<br /><br />de Belleroche J, Gardiner IM (1988) <br />Inhibitory effect of 1,2,3,4-tetrahydro-9-aminoacridine on the depolarization-induced release of GABA from cerebral cortex<br /><i>British Journal of Pharmacology</i> <b>94</b>: 1017<br /><br />